Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Palisade Bio, Inc.

Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Regains Compliance with Nasdaq Listing Requirements
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio is Granted Fast Track Designation from the U.S. Food and Drug Administration for LB1148 for Accelerated Return of Bowel Function following GI Surgery
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Appoints Herbert B. Slade, MD, FAAAAI as Chief Medical Officer
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Releases In-Depth Explanation of Scientific Approach of Lead Product Candidate LB1148 Through Animated Video
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Announces Reverse Stock Split
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Announces Executive Leadership Transition
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022
From Palisade Bio, Inc.
Via GlobeNewswire
Tickers PALI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.